2T9-33913-04034 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-14
Dose 1 — Pfizer-BioNTech
2021-01-27
Registered in v-safe
2021-01-28
Survey response — day 14, dose 1
MedDRA: Anxiety, Headache, Insomnia, Pre-existing disease — Feeling: Fair

Free text: Daily headaches. Increased anxiety symptoms at night. Insomnia.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-04
Dose 2 — Pfizer-BioNTech
2021-02-04
Survey response — day 0, dose 2
MedDRA: Hot flush — Feeling: Fair · Site: Pain · Headache

Free text: Hot flashes every 5-10 minutes.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-07
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Itching · Headache, Fatigue or tiredness

Adult check-in
2021-02-08
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache

Adult check-in
2021-02-09
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache

Adult check-in
2021-02-10
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Fatigue or tiredness

Adult check-in
2021-02-11
Health check-in — day 7, dose 2
Feeling: Fair · Headache, Fatigue or tiredness

Adult check-in
2021-02-18
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-25
Survey response — day 21, dose 2
MedDRA: Fatigue, Headache — Feeling: Fair

Free text: Very tired. Still having headaches every day.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-04
Survey response — day 28, dose 2
MedDRA: Rash — Feeling: Good

Free text: Unexplained painful rash on upper back.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-11
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-03-18
Health check-in — day 42, dose 2
Feeling: Fair

Adult check-in
2021-05-06
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-08-05
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-10-21
Dose 3 — Pfizer-BioNTech
Co-administered: Shingles
2022-02-04
Survey response — 12 months, dose 2
MedDRA: Dyspnoea, Fatigue, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities

Free text: Difficulty breathing, vision, fatigue.

MedDRA releases: 2024-11 · check-in free text available
2022-04-27
Dose 4 — Moderna
2022-05-05
Health check-in — day 7, dose 4
Feeling: Good · None

Adult check-in
2022-05-11
Health check-in — day 14, dose 4
Feeling: Good

Adult check-in
2022-05-18
Survey response — day 21, dose 4
MedDRA: Blindness unilateral, Eye pain, Visual impairment — Feeling: Good

Free text: Periodic left eye partial vision loss and pain.

MedDRA releases: 2024-11 · check-in free text available
2022-05-25
Health check-in — day 28, dose 4
Feeling: Good

Adult check-in
2022-06-01
Survey response — day 35, dose 4
MedDRA: Blindness transient, Blindness unilateral, Eye haemorrhage, Eye pain, Ocular discomfort — Feeling: Fair · Be unable to do your normal daily activities

Free text: Periodic loss of sight in left eye with pain/pressure. New right eye pain with broken blood vessels, also pain and discomfort.

MedDRA releases: 2024-11 · check-in free text available
2022-06-10
Survey response — day 42, dose 4
MedDRA: Surgery — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Surgery

MedDRA releases: 2024-11 · check-in free text available
2022-07-27
Survey response — 3 months, dose 4
MedDRA: Blindness unilateral — Feeling: Good

Free text: Periodic left eye vision loss

MedDRA releases: 2024-11 · check-in free text available
2022-10-26
Health check-in — 6 months, dose 4
Feeling: Good

Adult check-in
2023-04-27
Health check-in — 12 months, dose 4
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-14	Pfizer-BioNTech
2	2021-02-04	Pfizer-BioNTech
3	2021-10-21	Pfizer-BioNTech	Shingles
4	2022-04-27	Moderna	No

Free text

Release 2 — day 14, dose 1

2021-01-28

Symptoms: Daily headaches. Increased anxiety symptoms at night. Insomnia.

Release 3 — day 0, dose 2

2021-02-04

Systemic reaction (other): Hot flashes every 5-10 minutes.

Release 4 — day 21, dose 2

2021-02-25

Symptoms: Very tired. Still having headaches every day.

Release 5 — day 28, dose 2

2021-03-04

Symptoms: Unexplained painful rash on upper back.

Release 11 — 12 months, dose 2

2022-02-04

Symptoms: Difficulty breathing, vision, fatigue.

Release 11 — day 21, dose 4

2022-05-18

Symptoms: Periodic left eye partial vision loss and pain.

Release 11 — day 35, dose 4

2022-06-01

Symptoms: Periodic loss of sight in left eye with pain/pressure. New right eye pain with broken blood vessels, also pain and discomfort.

Release 12 — day 42, dose 4

2022-06-10

Symptoms: Surgery

Release 12 — 3 months, dose 4

2022-07-27

Symptoms: Periodic left eye vision loss

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Anxiety	✓	✓	✓
SD	Blindness transient	·	·	✓
SD	Blindness unilateral	·	·	✓
SD	Dyspnoea	·	·	✓
SD	Eye haemorrhage	·	·	✓
SD	Eye pain	·	·	✓
SD	Fatigue	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Insomnia	✓	✓	✓
SD	Ocular discomfort	·	·	✓
SD	Pre-existing disease	✓	✓	✓
SD	Rash	✓	✓	✓
SD	Surgery	·	·	✓
SD	Unevaluable event	·	·	✓
SD	Visual impairment	·	·	✓
SRO	Hot flush	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release